The chip maker's chief executive reiterated confidence in the strength of AI-driven semiconductor demand. How Moderna Went From Pandemic Hero to Vaccine Victim The biotech's mRNA vaccines were lauded ...

Bristol-Myers Squibb Company (NYSE:BMY), which focuses on innovative cancer and immunology treatments, is a leader in the ...

This study reveals the potential of engineered phage-IL-12 therapy in melanoma, enhancing immune response and tumor ...

Scientists say they have worked out a machine learning method with the ability to provide close to precise survival estimates ...

Despite the advancement of AI and machine learning technologies and their incorporation into cancer treatment and drug ...

The FDA granted de novo authorization to the first artificial intelligence (AI) program to support breast cancer risk ...

A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending ...

The Asia and Oceania Federation of Obstetrics and Gynecology (AOFOG) advocates for the vaccination of both females and males ...

Today, cancer stage and tumor size tell which patients will receive adjuvant chemotherapy. But the rise of biomarker testing ...

An AI test boosts cure chances for prostate cancer by predicting who benefits from abiraterone, reducing side effects and ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

Evaxion aims for at least 2 new deals in 2025 and is, in the meantime, further developing its AI platform to stay ahead of ...